Glucocorticoids (GCs) are used in moderate-to-severe
inflammatory bowel diseases (IBD) but their effect is often
unpredictable.These results confirm that genetic and demographic
factors may affect the response to GCs in young patients with IBD
and strengthen the importance of studying high-order interactions
for predicting response.
